Spectranetics manufactures and markets the only Excimer Laser System approved in the United States, Canada, Europe and Japan for use in minimally invasive interventional procedures within the cardiovascular system. More than 800 Spectranetics CVX-300® Excimer Laser Systems are used in hospitals worldwide.
The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of cardiac pacemaker and defibrillator leads.
The Company’s Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries in the legs, both above and below-the-knee, and within coronary arteries. The Company also markets aspiration catheters for the removal of thrombus as well as support catheters to facilitate crossing of coronary and peripheral arterial blockages.